BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 8585978)

  • 21. Establishment and characterization of a serous papillary adenocarcinoma cell line of the human ovary in a serum-free culture.
    Emoto M; Oshima K; Ishiguro M; Iwasaki H; Kawarabayashi T; Kikuchi M
    Pathol Res Pract; 1999; 195(4):237-42. PubMed ID: 10337661
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Genetic alterations in the genesis and development of ovarian cancer].
    Okamoto A; Yokoyama S; Terashima Y
    Gan To Kagaku Ryoho; 1992 Oct; 19(12):1971-6. PubMed ID: 1358031
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Overexpression and amplification of c-myc and c-Ha-ras oncogenes in pleomorphic salivary adenoma.
    Xue H; Situ ZQ; Wang CJ; Wu JZ
    Chin Med J (Engl); 1993 Jan; 106(1):22-5. PubMed ID: 8389270
    [TBL] [Abstract][Full Text] [Related]  

  • 24. ras gene activation and infrequent mutation in papillary serous carcinoma of the peritoneum.
    Garrett AP; Ng SW; Muto MG; Welch WR; Bell DA; Berkowitz RS; Mok SC
    Gynecol Oncol; 2000 Apr; 77(1):105-11. PubMed ID: 10739698
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Amplification of the N-myc oncogene in an adenocarcinoma of the lung.
    Saksela K; Bergh J; Nilsson K
    J Cell Biochem; 1986; 31(4):297-304. PubMed ID: 3020069
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Expression of c-myc and c-ki-ras oncogene in human pancreatic carcinoma].
    Li DC
    Zhonghua Zhong Liu Za Zhi; 1992 Jan; 14(1):30-2. PubMed ID: 1396043
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Amplifications of both c-Ki-ras with a point mutation and c-myc in a primary pancreatic cancer and its metastatic tumors in lymph nodes.
    Yamada H; Sakamoto H; Taira M; Nishimura S; Shimosato Y; Terada M; Sugimura T
    Jpn J Cancer Res; 1986 Apr; 77(4):370-5. PubMed ID: 3009377
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Correlation between DNA content and amplification of oncogenes (c-myc, L-myc, c-erbB-2) and correlation with prognosis in 143 cases of resected lung cancer].
    Chiba W; Sawai S; Hanawa T; Ishida H; Matsui T; Kosaba S; Watanabe S; Hatakenaka R; Matsubara Y; Funatsu T
    Gan To Kagaku Ryoho; 1993 Apr; 20(6):824-7. PubMed ID: 8098200
    [TBL] [Abstract][Full Text] [Related]  

  • 29. DNA amplification of the c-myc and c-erbB-1 genes in a human stomach cancer.
    Nomura N; Yamamoto T; Toyoshima K; Ohami H; Akimaru K; Sasaki S; Nakagami Y; Kanauchi H; Shoji T; Hiraoka Y
    Jpn J Cancer Res; 1986 Dec; 77(12):1188-92. PubMed ID: 3102422
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The amplification of c-myc, N-ras, c-erb B oncogenes in ovarian malignancies].
    Xin XY
    Zhonghua Fu Chan Ke Za Zhi; 1993 Jul; 28(7):405-7, 442. PubMed ID: 8287725
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Relationship between human papillomavirus and oncogenes (c-myc, N-myc) amplification in human cervical cancers].
    Kinoshita M; Ikei N; Shin S; Inui S; Hirao T; Aono T
    Nihon Gan Chiryo Gakkai Shi; 1990 Dec; 25(12):2828-35. PubMed ID: 1963632
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Activation of oncogenes in human oral cancer cells: a novel codon 13 mutation of c-H-ras-1 and concurrent amplifications of c-erbB-1 and c-myc.
    Tadokoro K; Ueda M; Ohshima T; Fujita K; Rikimaru K; Takahashi N; Enomoto S; Tsuchida N
    Oncogene; 1989 Apr; 4(4):499-505. PubMed ID: 2654810
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular genetics of malignant insulinoma.
    Pavelic K; Hrascan R; Kapitanovic S; Vranes Z; Cabrijan T; Spaventi S; Korsic M; Krizanac S; Li YQ; Stambrook P; Gluckman JL; Pavelic ZP
    Anticancer Res; 1996; 16(4A):1707-17. PubMed ID: 8712689
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Studies on the point mutation of ras oncogene in ovarian tumor].
    Fujimoto I; Shimizu Y; Umezawa S; Katase K; Hirai Y; Yamauchi K; Hasumi K
    Nihon Sanka Fujinka Gakkai Zasshi; 1993 Nov; 45(11):1289-96. PubMed ID: 8258728
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Alterations of c-Myc and c-erbB-2 genes in ovarian tumours].
    Pastor T; Popović B; Gvozdenović A; Boro A; Petrović B; Novaković I; Puzović D; Luković L; Milasin J
    Srp Arh Celok Lek; 2009; 137(1-2):47-51. PubMed ID: 19370966
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [New technology of diagnosis of ovarian cancer].
    Terashima Y
    Gan No Rinsho; 1988 Aug; 34(10):1427-31. PubMed ID: 2845169
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Correlation between hypomethylation of c-myc and c-N-ras oncogenes and pathological changes in human hepatocellular carcinoma].
    Shen L; Qui D; Fang J
    Zhonghua Zhong Liu Za Zhi; 1997 May; 19(3):173-6. PubMed ID: 10920889
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Oncogene ZNF217 amplification on chromosome 20 q in ovarian serous cystadenocarcinoma and its clinical implications].
    Li J; Zhong M; Song LL; Su GD
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 Jun; 26(6):824-5. PubMed ID: 16793610
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Correlations between c-myc gene copy-number and clinicopathological parameters of ovarian tumours.
    Dimova I; Raitcheva S; Dimitrov R; Doganov N; Toncheva D
    Eur J Cancer; 2006 Mar; 42(5):674-9. PubMed ID: 16458500
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Detection of 8 oncogenes in squamous epithelial cancers of the head and neck].
    Jungehülsing M; Volling P
    HNO; 1994 May; 42(5):280-7. PubMed ID: 8050916
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.